Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US, Journal of Comparable Effectiveness Research (2025) FDA approves weight management drug for patients aged 12 and older, FDA (2020) Generic drugs: Questions & answers, FDA (2021) Liraglutide injection (weight management), Cleveland Clinic (2025) Liraglutide, StatPearls (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva (2025) Top weight loss medications, Obesity Medicine Association (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Week-by-Week Progress: Your First Month on GLP-1 Week 1: Adjusting to GLP-1 Treatment During the first week, your body starts adapting to the medication
This could be beneficial for individuals with insulin resistance or those trying to maintain healthy blood sugar levels
GLP-1 secretion is glucose-dependent, and beyond its insulinotropic action, it suppresses glucagon release, delays gastric emptying, and reduces appetite, making it an important regulator of energy balance
34 HillE
Hum Reprod 23:16981707